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The in situ formed ruthenium catalytic system ([Ru]/L) was found to be highly selective for the dehydrogenative 
coupling reaction of 2-aminophenyl ketones with amines to form quinazoline products. The deaminative 
coupling reaction of 2-aminobenzamides with amines led to the efficient formation of quinazolinone products. 
The catalytic coupling method provides an efficient synthesis of quinazoline and quinazolinone derivatives 
without using any reactive reagents or forming any toxic byproducts. 
Quinazolines and quinazolinones are a privileged class of nitrogen heterocyclic scaffolds that have been found to 
exhibit a broad spectrum of pharmacological activities, including anti-inflammatory, antitubercular, and antiviral 
activities.(1) A number of quinazoline-based drugs such as prazocin and doxazosine have been approved to treat 
benign prostatic hyperplasia and post-traumatic stress disorder,(2) while both erlotinib and gefitinib have been 
used for the treatment of lung and pancreatic cancers (Figure 1).(3) Lapatinib, as an inhibitor for epidermal 
growth factor, has been shown to be effective in combination therapy for breast cancer.(4) Several 
quinazolinone-based drugs including idelalisib and fenquizone have been shown to exhibit a broad spectrum of 
antimicrobial, antitumor, antifungal, and cytotoxic activities.(5) 
 
Figure 1. Selected examples of quinazoline and quinazolinone-based drugs. 
A number of different synthetic strategies for quinazolines and quinazolinones have been developed over the 
years, in part to meet the growing needs for screening such derivatives.(6) Several research groups have 
successfully utilized copper-catalyzed Ullmann-type coupling methods of aryl bromides and benzamidines for 
the synthesis of quinazoline derivatives.(7) Similar Cu-catalyzed oxidative coupling methods of aniline 
derivatives with aldehydes and nitriles have also been developed for the construction of quinoline core 
structures.(8) Transition-metal-catalyzed oxidative C–H amination and alkylation methods have also been 
successfully employed to synthesize quinazoline and quinazolinone derivatives.(9) Cho and co-workers recently 
devised a practical synthesis of 2-arylquinazoline derivatives from the coupling of 2-aminobezylamines with 
halogenated toluene substrates.(10) 
Since the advent of the Niementowski condensation of anthranilic acids with amides,(11) a variety of sustainable 
synthetic methods have also been devised for the assembly of quinazolinone core structures.(12) Much recent 
research effort has been devoted to the development of catalytic coupling methods to increase efficiency and 
selectivity in constructing quinazolinone core structures. A number of transition-metal-catalyzed direct coupling 
methods of aminobenzamides with alcohols and carbonyl compounds have been successfully exploited to 
synthesize quinazolinone derivatives.(13) Transition-metal-catalyzed couplings of 2-aminobenzamides with 
alcohols and ketones(14) and three-component couplings of 2-aminobenzamides, aryl halides or equivalents, 
and isocyanides(15) are among the notable examples of catalytic synthesis of quinazolinones. 
We previously reported that a phenol-coordinated cationic ruthenium–hydride complex is a highly effective 
catalyst for mediating the hydrogenolysis of aldehydes and ketones to give the corresponding aliphatic 
products.(16) We subsequently devised a catalytic system generated in situ from a tetranuclear ruthenium–
hydride complex and a catechol ligand to promote a direct deaminative coupling of primary amines.(17) We 
have been exploring the coupling reactions of amines to further extend the synthetic utility of ligand-promoted 
catalysis, and herein, we disclose an efficient catalytic synthesis of quinazoline and quinazolinone derivatives 
from the dehydrogenative and deaminative coupling reactions of amino ketones and aminobenzamides with 
amines. 
 
In an effort to extend the scope and utility of deaminative coupling methods, we initially explored the coupling 
reaction of 2-amino ketones with amines by employing the ligand-promoted catalysis protocol. Among the 
initially screened Ru catalysts and ligands, the in situ generated catalytic system from the cationic ruthenium–
hydride complex [(C6H6)(PCy3)(CO)RuH]+BF4– (1) with 4-(1,1-dimethylethyl)-1,2-benzenediol (L1) was found to 
give the highest activity and selectivity for the coupling of 2-(aminophenyl)ethanone with 4-
methoxybenzylamine in yielding the quinazoline product 2a (Table S1). After further ligand screening and 
optimization studies, we established the standard conditions for the quinazoline product 2a as 1 (3 mol %) and 
4-(1,1-dimethylethyl)-1,2-benzenediol (L1) (10 mol %) in 1,4-dioxane (2 mL) at 140 °C (eq 1). 
We explored the substrate scope of the coupling reaction by using the catalyst system 1/L1 under the standard 
conditions (Table1). The coupling of 2-aminophenyl ketones with a variety of benzylic amines selectively formed 
the quinazoline products 2a–o. The coupling of 2-aminophenyl ketones with phenethylamines and with aliphatic 
amines also gave the selective formation of 2q,r and 2s–u, respectively. While the coupling reaction of 2-
aminphenyl ketone substrate with a branched amine smoothly yielded the coupling products 2v and 2cc, 
coupling with sterically demanding secondary amines and branched amines generally yielded only a trace 
amount of the coupling products under the standard reaction conditions. 
  
Table 1. Synthesis of Quinazolines from the Coupling of 2-Aminophenyl Ketones with Aminesa 
 
aReaction conditions: amino ketone (0.5 mmol), amine (0.7 mmol), 1 (3 mol %), L1 (10 mol %), dioxane (2 mL), 
140 °C, 20 h. Ar = 3,4,5-trimethoxyphenyl, Ar′= 3,5-methylenedioxybenzyl. 
Analytically pure quinazoline products were readily isolated after silica gel column chromatographic separation, 
and their structures were completely established by spectroscopic methods. The structure of 2j was also 
confirmed by X-ray crystallography. The coupling reaction was easily scalable to a 2–3 mmol scale reaction to 
yield 0.5–0.7 g of 2b, 2l and 2z. The catalytic coupling method furnishes a direct synthesis of quinazoline 
products without resorting to employing any reactive reagents. 
 
Adopting the previously developed deaminative coupling protocol,(17) we next sought the catalytic coupling 
reaction of the arylamides with amine substrates to form quinazolinone products. Thus, the treatment of 2-
aminobenzamide (0.5 mmol) with benzylamine (0.7 mmol) in dioxane (2 mL) at 140 °C in the presence of the 
catalyst system 1 (3 mol %)/L1 (10 mol %) led to the selective formation of the quinazolinone product 3a, which 
was analyzed by both GC and NMR spectroscopic methods (eq 2). 
The substrate scope of the coupling reaction was explored by using the catalyst system 1/L1 under the standard 
conditions (Table2). The coupling of 2-aminobenzamides with both benzyl- and alkyl-substituted amines led to 
the selective formation of the quinazolinone products 3a–n with no significant amount of the quinazoline or 
other side products. The analogous coupling reaction of N-alkyl-2-benzamides with both benzylamines and alkyl-
substituted amines afforded the corresponding coupling products 3o–t in moderate to high yields. 
  
Table 2. Synthesis of Quinazolinones from the Coupling of 2-Aminobenzamides with Aminesa 
 
aReaction conditions: benzamide (0.5 mmol), amine (0.7 mmol), 1 (3 mol %), L1 (10 mol %), dioxane (2 mL), 140 
°C, 20 h. 
Single crystals of 3c were obtained by slow evaporation in hexanes/EtOAc at room temperature, and its 
structure was determined by X-ray crystallography. The formation of quinazolinone product can be rationalized 
by initial deaminative coupling of amide and amine substrates followed by the cyclization dehydrogenation 
steps. The coupling reaction efficiently assembles synthetically valuable quinazolinone core structures by 
employing readily available amine and benzamide substrates. 
To further demonstrate synthetic utility of the catalytic method, we next performed the couplings of both 2-
aminophenyl ketones and 2-aminobenzamides with a number of biologically active amine substrates (Table3). 
The treatment of 2-aminophenylethanone with tryptamine under the standard conditions led to the indole-
substituted product 2ff. The analogous coupling with (−)-cis-myrtanylamine formed the quinazoline 
product 2gg (dr = 10:1) with a minimal racemization on the benzylic carbon. The coupling of 2-
aminophenylethanone with a morpholinyl-substituted amine predictively formed 2ii. The coupling of a 
thiophene-substituted amino ketone with 3,4,5-trimethoxybenzylamine yielded the product 2jj in 52% yield. The 
analogous treatment of 2-aminobenzamide with geranylamine formed the corresponding quinazolinone 
product 3u, in which the neighboring olefinic group is selectively hydrogenated, while the treatment of a 
thiophene-substituted amide with 4-phenylbenzylamine formed the corresponding quinazolinone product 3v. 
The coupling of 2-aminobenzamide with (−)-cis-myrtanylamine formed the coupling product 3w with a modest 
diastereoselectivity (dr = 1.9:1). In sharp contrast, the analogous coupling with (+)-dehydroabietylamine resulted 
in the formation of the coupling product 3x without any detectable racemization. The structure and 
stereochemistry of both 3w (major diastereomer) and 3x have been confirmed by X-ray crystallography. 
 
 
 Table 3. Coupling Reaction of 2-Aminophenyl Ketones and 2-Aminobenzamides with Biologically Active Aminesa 
 
aReaction conditions: amino ketone or benzamide (0.5 mmol), amine (0.7 mmol), 1 (3 mol %), L1 (10 mol %), 
dioxane (2 mL), 140 °C, 20 h. 
bBenzamide (0.25 mmol), amine (0.35 mmol). 
We performed the following set of experiments to probe mechanistic insights on the coupling reaction. First, we 
examined the deuterium-labeling pattern from the reaction of 2-aminophenylethanone-d3 (89% D) with 4-
methoxybenzylamine (eq 3). The treatment of 2-aminophenylethanone-d3 (0.5 mmol) with 4-
methoxybenzylamine (0.7 mmol) in the presence of 1 (3 mol %)/L1 (10 mol %) in 1,4-dioxane (2 mL) was heated 
in an oil bath at 140 °C for 20 h. The isolated product 2a-d as analyzed by 1H and 2H NMR contained only 11% of 
the deuterium on the methyl group as most of the deuterium had been washed away (Figure S1). A relatively 
small amount of the deuterium on 2a-d suggests an extensive keto–enol tautomerization under the reaction 
conditions. 
We next monitored the reaction progress by using NMR spectroscopy to discern intermediate species for the 
coupling reaction. In a resealable NMR tube, a reaction mixture of 2-aminophenylethanone (0.25 mmol), 4-
methoxybenzylamine (0.25 mmol), and in situ generated catalyst 1 (3 mol %)/L1 (10 mol %) in toluene-d8 (0.5 
mL) was immersed an oil bath set at 140 °C. The tube was taken out from the oil bath at 20 min intervals, and 
the reaction progress was recorded by 1H NMR. The appearance of new set of peaks attributed to the imine 
product 4a has been observed initially as both starting substrates are consumed. After about 100 min of 
reaction time, the peaks due to the quinazoline product 2a began to appear as the imine peaks gradually 
disappeared. The plot of relative concentration vs time is shown in Figure 2. 
 
 Figure 2. Plot of relative concentration vs time for the coupling reaction of 2-aminophenylethanone (■) with 4-
methoxybenzylamine (●), 2a (⧫), and 4a (▲). 
To establish the imine as a requisite intermediate for the formation of 2, independently synthesized 4b was 
treated with 1/L1 under the standard conditions, which proceeded smoothly to afford the quinazoline 
product 2h in 87% yield (eq 4). In a control experiment, the analogous treatment of 4b with p-toluenesulfonic 
acid (5 mol %) did not form the product 2h under otherwise similar reaction conditions. The results showed that 
the ruthenium catalysis is essential for the cyclization and dehydrogenation steps of the product formation. 
Although much kinetic and spectroscopic information is still needed to ascertain a detailed reaction mechanism, 
we offer a plausible mechanistic sequence for the formation of quinazoline products 2 on the basis of these 
preliminary results (Scheme 1). The reaction profile study clearly implicates that the imine intermediate 4 is 
generated from initial dehydrative coupling of amino ketone and amine substrates. We propose that the Ru 
catalyst facilitates the imine isomerization to form the imine-coordinated species 5. The subsequent cyclization 
and dehydrogenation steps would yield the quinazoline product 2. In support of this, we previously found that 
the ruthenium–hydride complexes are efficient catalysts for olefin isomerization reaction(18) and 
dehydrogenation of saturated amines and carbonyl compounds.(19) While the exact role of catechol ligand has 
yet to be established, we believe that a redox-active catechol ligand may be facilitating the dehydrogenation 
step on the catalysis.(20) 
 Scheme 1. Possible Mechanistic Sequence for the Formation of Quinazoline Products 
In summary, we have been able to devise a catalytic protocol for the synthesis of quinazoline and quinazolinone 
derivatives from the dehydrogenative and deaminative couplings of 2-aminophenyl ketones and 2-
aminobenzamides with amines. The in situ formed ruthenium–hydride complex with a catechol ligand (1/L1) 
was found to exhibit uniquely high catalytic activity and selectivity in forming these products. The salient 
features of the catalytic method are that it employs readily available substrates, exhibits a broad substrate 
scope while tolerating common organic functional groups, and does not require any reactive reagents or forms 
any wasteful byproducts. We are currently exploring synthetic utility of the deaminative coupling protocol in 
constructing other nitrogen heterocyclic core structures. 
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